1. From the Tumor Immunology Program, Division of Immunogenetics, and the Division of Molecular Biology of the Cell I, German Cancer Research Center (DKFZ), Heidelberg, Germany; and Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany.